Cargando…

Clinical trials in dermatology

Clinical trials are the backbone of modern day medicine. Randomized, double-blinded, placebo-controlled studies are critical for advancement in medicine and dermatology. Skin conditions such as psoriasis and atopic dermatitis are among the most common health problems in the United States. Clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Torre, K., Shahriari, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555277/
https://www.ncbi.nlm.nih.gov/pubmed/28831432
http://dx.doi.org/10.1016/j.ijwd.2016.12.001
_version_ 1783256903551287296
author Torre, K.
Shahriari, M.
author_facet Torre, K.
Shahriari, M.
author_sort Torre, K.
collection PubMed
description Clinical trials are the backbone of modern day medicine. Randomized, double-blinded, placebo-controlled studies are critical for advancement in medicine and dermatology. Skin conditions such as psoriasis and atopic dermatitis are among the most common health problems in the United States. Clinical trials can provide treatments that not only offer objective improvements in clinical disease status but also subjective improvements in the quality of life of patients who are afflicted with the disease. In this article, we discuss the processes and resources of a clinical trials unit and the challenges that can be encountered during the study process. It is critical to engage in clinical trials to treat patients most effectively with new and innovative therapies that are rooted in trial-validated, evidence-based medicine.
format Online
Article
Text
id pubmed-5555277
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-55552772017-08-22 Clinical trials in dermatology Torre, K. Shahriari, M. Int J Womens Dermatol Review Clinical trials are the backbone of modern day medicine. Randomized, double-blinded, placebo-controlled studies are critical for advancement in medicine and dermatology. Skin conditions such as psoriasis and atopic dermatitis are among the most common health problems in the United States. Clinical trials can provide treatments that not only offer objective improvements in clinical disease status but also subjective improvements in the quality of life of patients who are afflicted with the disease. In this article, we discuss the processes and resources of a clinical trials unit and the challenges that can be encountered during the study process. It is critical to engage in clinical trials to treat patients most effectively with new and innovative therapies that are rooted in trial-validated, evidence-based medicine. Elsevier 2017-01-27 /pmc/articles/PMC5555277/ /pubmed/28831432 http://dx.doi.org/10.1016/j.ijwd.2016.12.001 Text en © 2016 Women's Dermatologic Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Torre, K.
Shahriari, M.
Clinical trials in dermatology
title Clinical trials in dermatology
title_full Clinical trials in dermatology
title_fullStr Clinical trials in dermatology
title_full_unstemmed Clinical trials in dermatology
title_short Clinical trials in dermatology
title_sort clinical trials in dermatology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555277/
https://www.ncbi.nlm.nih.gov/pubmed/28831432
http://dx.doi.org/10.1016/j.ijwd.2016.12.001
work_keys_str_mv AT torrek clinicaltrialsindermatology
AT shahriarim clinicaltrialsindermatology